Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Urinary Bladder Neoplasms × 30 days × Clear all

Phase

Status

Recruiting 54 Active not recruiting 34 Completed 12 Not yet recruiting 6 Terminated 4 Enrolling by invitation 2 Withdrawn 1 Suspended 1 Available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 3 Lung Neoplasms 3 Breast Neoplasms 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, B-Cell 2 Lymphoma 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Vasculitis 1 Urinary Bladder Neoplasms 1 Ulcer 1 Stomatitis 1 Spondylarthritis 1 Spinal Cord Neoplasms 1 Solid Tumor 1 Smoke Inhalation Injury 1 Sjogren's Syndrome 1 Scleroderma, Diffuse 1 Respiratory Aspiration 1 Recurrence 1 Rare Diseases 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Myositis 1 Multiple Myeloma 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Melanoma 1 Mastocytosis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02143804 2026-04-02

exBOND

CG Oncology, Inc.

Phase 2 Withdrawn

Adenoviridae Infections, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡